The global burn care market size was estimated at USD 1.77 billion in 2017. It is anticipated to register a CAGR of 6.8% over the forecast period. Increasing incidence of burn-related injuries is anticipated to drive the growth. Rising demand for minimally invasive and cosmetic procedures to restore appearance of patients suffering from burns is a key contributing factor for the growth.
Moreover, rising concerns regarding aesthetic appearance among patients are among major factors contributing to upsurge in demand for burn care products. Furthermore, advantages associated with use of biologics, such as accelerated wound healing, cost efficiency, and shorter hospital stay are expected to drive the market in near future.
Rising demand for skin grafts is also a major growth contributor to this market. Skin grafts are majorly used on partial and full thickness burns and plays an important role in the treatment of burn injuries. Skin grafts allow excellent epithelialization due to the presence of basement membrane and show larger control over scaffold composition. They also have advantages over other dressing materials, as they do not require frequent changing. Due to the aforementioned benefits, there is high demand for skin grafts, which, in turn, is expected to boost the growth of the market.
Increasing awareness among people regarding availability of various treatment options related to burn care management is anticipated to boost market growth. Rising disposable income in developing economies and willingness to opt for new and advanced wound care products, especially in case of patients affected with severe burns are driving the demand.
Different treatment options include advanced dressings, traditional products, biologics, and other pressure therapies. Advanced dressings include alginate dressings, hydrogel dressings, foam dressings, hydrocolloid dressings, collagen dressings, and others. Biologics segment includes skin grafts, whereas traditional products include tapes and other commonly used dressings.
Advance dressing products held a dominant share in the market in 2017, owing to higher penetration rate in developed countries. Benefits associated with use of these products, such as ease of use, lesser recovery time, and cost efficiency are leading to rise in product adoption.
Collagen dressings held the dominant share within the advanced dressing segment in 2017, due to its ability to lower the risk of infection in wounds. It helps minimize irritation, keeps the wound moist and soft, and is available in variety of shapes and sizes. The aforementioned benefits are expected to fuel the demand in near future. Other advance dressing products include alginate, hydrogel, foam, and film dressing, of which, hydrogel is anticipated to witness significant growth over the forecast period due to rising awareness among patients and healthcare professionals.
Biologics, such as skin grafts and substitutes, bio-membrane, interleukin-8, and fibroblast are expected to display lucrative growth in the forthcoming years. Biologic dressings prevent heat loss, water loss, protein and electrolyte loss, and contamination. Technological advancements for the development of skin substitutes such as collagen-synthetic bilaminates and tissue culture-derived membranes are anticipated to boost market growth.
Incidence of minor burn injuries is higher than partial and full-thickness injuries. In terms of revenue, the full thickness injuries held the dominant market share as the treatment requires long-term observation and care.
Minor wound segment is expected to showcase the fastest CAGR over the next few years as these wounds have the potential to develop into acute and chronic wounds. To treat this condition, clinicians require a thorough understanding to perform outside interventions for proper healing of wounds. This increases the number of patient visits to the clinician’s office.
Minor burns can be treated with advanced or traditional dressing products and can recover in less amount of time. Collagen sheets are more useful in treating minor wounds. These sheets are non-inflammatory and facilitate fibroblast migration, which helps in wound healing. Some of the commonly known collagen sheets are Xenostat manufactured by Helix Pharma, Kollagen-M, and NeuSkin by Eucare Pharmaceuticals Pvt. Ltd.
Chronic wounds include partial thickness and full thickness burns. These conditions take longer time to heal as they cover more than 15% of the body. These wounds can be caused by various external factors such as electricity, radiation, friction, chemicals, respiratory, and thermal objects. Skin grafts are used to treat partial and full-thickness injuries. Skin grafts offer more intact extracellular matrix, which aids in faster healing.
Thermal burns held the largest share in the global burn care market in 2017 owing to a rising incidence of fire-related burn injuries, such as the burns caused by fires, steam, flash, hot objects, and hot liquids. According to the American Burn Association (ABA), in 2017, fire burns were responsible for 43% of the total burn admissions in the U.S. Moreover, rising government efforts to create awareness through campaigns, such as the Burn Awareness Week organized by the American Burn Association and BBA National Burns Awareness Days by British Burn Association, will further fuel the segment growth.
The others segment is expected to witness lucrative growth over the forecast period. It includes all burns caused due to friction, abuse, and other causes. Friction burns are caused due to abrasions owing to the skin rubbing against any hard surface. The incidence of friction burns is high, but the majority of these burns are minor in nature, hence, patients do not visit the hospital for treatment.
According to the American Society for Radiation Oncology, around 95% of patients undergoing radiation therapy suffer from some degree of radiodermatitis. Among these, 85% patients experience severe-to-moderate form of radiodermatitis. The severity depends on the volume of tissues irradiated, location, and total radiation dose received; body surface area of treatment, and the duration of radiation. Thus, the radiation burns segment is anticipated to register a significant CAGR of 7.4% during forecast period.
Hospitals held the largest market share in 2017, due to increasing incidence of partial and full-thickness injuries. The most commonly used treatment products from MNC brands like Johnson & Johnson, Smith & Nephew, and 3M.
The majority of the injuries are of partial or full thickness, which require immediate medical attention. This is contributing to the growth of this segment. Hospitals are further classified into inpatient and outpatient care facilities. Outpatient care units held the dominant share in 2017 as majority of cases are partial injuries that do not require hospitalization.
The clinic segment is expected to witness steady growth in near future owing to growing penetration of standalone clinics in metro cities. Clinics offer traditional and advanced wound care products on a large scale. The higher penetration of the facilities is expected to be responsible for the rising revenue share of the segment during the forecast period.
The home care and long-term care centers are included in the others end-use segment. This segment is anticipated to exhibit lucrative growth over the forecast period. Increased awareness pertinent to the available treatment options and concern for personalized treatment is contributing to the growing penetration of burn cure at home care settings.
North America dominated the market in 2017 attributed to the shift from traditional treatment products to the advanced wound dressing products. This is due to the rising concern toward aesthetic appearance and demand for minimally invasive cosmetic surgeries in this region.
For instance, statistics published by the American Society of Plastic Surgeons indicate that in 2017, around 17.5 million minimally invasive and surgical cosmetic procedures were performed in U.S. The number is expected to increase over the forecast period. Thus, high demand of cosmetic procedures is considered to be one of the key contributing factors for the rising demand of biologics to treat wounds, which, in turn, is projected to drive the regional market.
The presence of well-established healthcare facilities, favorable reimbursement policies, and advanced therapies are some of the key contributing factors for market growth in developing economies such as India, China, and Brazil. In addition, adoption of technologically advanced surgeries such as reconstructive burn surgery is also anticipated to propel regional market growth.
Asia Pacific is anticipated to witness lucrative CAGR in the forthcoming years. Emerging economies such as China, and India have been experiencing strong economic growth. Increasing standard of living in these countries has spurred the demand for advanced products and procedures. Rising disposable income is expected to trigger the regional demand for cosmetic procedures in near future.
The global market is anticipated to witness intense competition over the forecast period. It is consolidated in nature, with few players such as Johnson & Johnson, Smith & Nephew, Mölnlycke Health Care AB, ConvaTec Inc., and Acelity L.P. Inc. dominating the market. Market participants are adopting strategies to capture market share such as new product developments, geographic expansion via enhancing the distribution network, and mergers and acquisitions.
For instance, in January 2017, Derma Sciences, Inc. acquired MEDIHONEY brand from Comvita Limited, a company based in New Zealand, in a probe to increase its advanced wound care product portfolio. In February 2016, Acelity L.P. Inc. entered into a partnership agreement with Mediq for the enhancement of its distribution network for advanced wound care products in Denmark, Norway, Finland, and Sweden. Thus, similar strategic initiatives are expected to fuel competition over the forecast period.
Base year for estimation
Actual estimates/Historical data
2014 - 2016
2018 - 2025
Revenue in USD Million & CAGR from 2017 to 2025
North America, Europe, Asia Pacific, Latin America & MEA
U.S., Canada, U.K., Germany, Italy, France, Spain, Japan, India, China, Brazil, Mexico, South Africa
Revenue forecast, company share, competitive landscape, growth factors and trends
15% free customization scope (equivalent to 5 analyst working days)
If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global burn care market report on the basis of product, depth of wound, cause, end-use, and region:
Product Outlook (Revenue, USD Million, 2014 - 2025)
Wound Contact Layers
Depth of Wound Outlook (Revenue, USD Million, 2014 - 2025)
Cause Outlook (Revenue, USD Million, 2014 - 2025)
End-use Outlook (Revenue, USD Million, 2014 - 2025)
Regional Outlook (Revenue, USD Million, 2014 - 2025)
Middle East & Africa
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."